当前位置: 首页 > 新药研发 >帕布昔里布的粒径问题

帕布昔里布的粒径问题

作者 xuekaiaabb
来源: 小木虫 200 4 举报帖子
+关注

国内已经申报成功的粒径控到什么范围?具体如何控制的?

 返回小木虫查看更多

今日热帖
  • 精华评论
  • 凌宇雷池

    恕我直言 已经申报的具体内容,是不会告诉你的 也是不公开的

  • kdl0721

    Using the developed process, more than 30 pilot-plant and commercial manufacturing scale batches of palbociclib have
    been manufactured with a D(50) particle size in the range of 12.14 μm.

  • kdl0721

    Using the developed process, more than 30 pilot-plant and commercial manufacturing scale batches of palbociclib have
    been manufactured with a D(50) particle size in the range of 12-14 μm.

  • kdl0721

    国内已经申报成功的粒径控范围也不能参考,还是要参考原研。可以看下这片文章:Palbociclib Commercial Manufacturing Process Development. Part III. Deprotection Followed by Crystallization for API Particle Property Control,

猜你喜欢